Australian National Diabetes Audit – Australian Quality Clinical Audit (ANDA-AQCA) 2021

We are now seeking expressions of interest from diabetes centres to participate in ANDA-AQCA 2021. All types of centres from tertiary to primary care may participate.

The primary aim of ANDA-AQCA is to:

1. conduct a survey that will assess a standardised set of predefined clinical diabetes indicators including demographic and biological variables, and clinical outcomes
2. enable diabetes services to benchmark their practice processes and clinical outcome data against that of other centres;
3. enable diabetes services to compare their practice processes and clinical outcome data over time (where participation in previous collections has occurred);
4.  provide pooled national data and data grouped by state and metropolitan/regional/ remote location on the clinical status of people with diabetes attending diabetes services.

This important quality assurance activity promotes continuous improvement in the standard of service provided by diabetes centres and is the primary quality assurance activity of the NADC.
The success of this activity is dependent on a maximum level of participation by centres.

The following is the proposed Timetable for the Survey in (enter year of audit):
Formal Invitation to Join now

• Distribution of Survey Forms in April
• Data Collection (for 4 weeks) in May or June

Note: The survey can be conducted over 8 weeks [May and June] for centres not able to collect data on more than 30 participants during this period

To view the invitation and registration form, go to nadc.net.au/anda